Edbrooke M R, Burt D W, Cheshire J K, Woo P
Section of Molecular Rheumatology, MRC Clinical Research Centre, Harrow, Middlesex, United Kingdom.
Mol Cell Biol. 1989 May;9(5):1908-16. doi: 10.1128/mcb.9.5.1908-1916.1989.
We have analyzed the 5'-flanking region of one of the genes coding for the human acute-phase protein, serum amyloid A (SAA). We found that SAA mRNA could be increased fivefold in transfected cells by treatment with phorbol 12-myristate 13-acetate (PMA). To analyze this observation further, we placed a 265-base-pair 5' SAA fragment upstream of the reporter chloramphenicol acetyltransferase (CAT) gene and transfected this construct into HeLa cells. PMA treatment of these transient transfectants resulted in increased CAT expression. Nuclear proteins from PMA-treated HeLa cells bound to this DNA fragment, and methylation interference analysis showed that the binding was specific to the sequence GGGACTTTCC (between -82 and -91), a sequence previously described by R. Sen and D. Baltimore (Cell 46:705-716, 1986) as the binding site for the nuclear factor NF kappa B. In a cotransfection competition experiment, we could abolish PMA-induced CAT activity by using cloned human immunodeficiency virus long-terminal-repeat DNA containing the NF kappa B-binding sequence. The same long-terminal-repeat DNA containing mutant NF kappa B-binding sequences (G. Nabel and D. Baltimore, Nature [London] 326:711-713, 1987) did not affect CAT expression, which suggested that binding by an NF kappa B-like factor is required for increased SAA transcription.
我们分析了编码人类急性期蛋白血清淀粉样蛋白A(SAA)的其中一个基因的5'侧翼区。我们发现,用佛波酯12 -肉豆蔻酸酯13 -乙酸酯(PMA)处理转染细胞后,SAA mRNA可增加五倍。为了进一步分析这一观察结果,我们将一个265个碱基对的SAA 5'片段置于报告氯霉素乙酰转移酶(CAT)基因的上游,并将该构建体转染到HeLa细胞中。用PMA处理这些瞬时转染细胞导致CAT表达增加。来自PMA处理的HeLa细胞的核蛋白与该DNA片段结合,甲基化干扰分析表明该结合对序列GGGACTTTCC(在-82至-91之间)具有特异性,该序列先前被R. Sen和D. Baltimore(《细胞》46:705 - 716,1986)描述为核因子NF-κB的结合位点。在共转染竞争实验中,我们可以通过使用含有NF-κB结合序列的克隆人免疫缺陷病毒长末端重复DNA来消除PMA诱导的CAT活性。含有突变NF-κB结合序列的相同长末端重复DNA(G. Nabel和D. Baltimore,《自然》[伦敦]326:711 - 713,1987)不影响CAT表达,这表明SAA转录增加需要NF-κB样因子的结合。